GHRL and obesity disorder: Importantly, some recent research also described alterations of the concentrations and regulations of some key physiological actors involved in the control of appetite (ghrelin, peptide YY3-36, or cholecystokinin) in adults with obesity diagnosed with a metabolic syndrome [15,16].